Evidence map›Paper›PMID 26324408›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking.

In-Jee You, Sherie R Wright, Alvaro L Garcia-Garcia, Andrew R Tapper, Paul D Gardner, George F Koob, E David Leonardo, Laura M Bohn, Sunmee Wee

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Constitutive and Conditional Epitope Tagging of Endogenous G-Protein-Coupled Receptors inThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  6. Article
  7. GMolecular pharmacology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  12. Article
  13. Article
  14. Animal Models of the Behavioral Symptoms of Substance Use Disorders.Cold Spring Harbor perspectives in medicine · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

In-Jee YouDepartment of Psychiatry, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA, USA.
Sherie R WrightDepartment of Molecular Therapeutics, The Scripps Research Institute-Florida, Jupiter, FL, USA.
Alvaro L Garcia-GarciaDepartment of Psychiatry, Columbia University, New York, NY, USA.
Andrew R TapperDepartment of Psychiatry, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA, USA.
Paul D GardnerDepartment of Psychiatry, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA, USA.
George F KoobCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
E David LeonardoDepartment of Psychiatry, Columbia University, New York, NY, USA.
Laura M BohnDepartment of Molecular Therapeutics, The Scripps Research Institute-Florida, Jupiter, FL, USA.
Sunmee WeeDepartment of Molecular Therapeutics, The Scripps Research Institute-Florida, Jupiter, FL, USA.
Scripps Research Institute · USNeuropsychiatric Research Institute · USColumbia University · USNew York State Psychiatric Institute

Funding

Neurobiology of AddictionZICDA000602 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KOOB, GEORGE · 2015 to 2018
$5.4M
NEURONAL SUBSTRATES OF COCAINE REWARDR01DA004398 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI GEORGE, OLIVIER · 1987 to 2014
$4.9M
A Late Sensitive Period for the Development of Anxiety DisordersR01MH091427 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI LEONARDO, EDUARDO DAVID · 2010 to 2014
$2.0M
Neurocircuitry of Nicotine DependenceR01DA035371 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GARDNER, PAUL D, TAPPER, ANDREW R · 2014 to 2018
$1.9M
Role of the 5-HT1A Receptors in Cocaine DependenceR00DA025785 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI WEE, SUNMEE · 2012 to 2014
$748k
Role of the 5-HT1A Receptors in Cocaine DependenceK99DA025785 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI WEE, SUNMEE · 2009 to 2010
$184k
NIDA NIH HHS DA004398NIDA NIH HHS DA025785NIDA NIH HHS DA035371NIDA NIH HHS K99 DA025785NIDA NIH HHS R00 DA025785NIDA NIH HHS R01 DA004398NIDA NIH HHS R01 DA035371NIMH NIH HHS MH91427NIMH NIH HHS R01 MH091427
6 · The paper itself

Abstract

Cocaine addiction and depression are comorbid disorders. Although it is well recognized that 5-hydroxytryptamine (5-HT; serotonin) plays a central role in depression, our understanding of its role in addiction is notably lacking. The 5-HT system in the brain is carefully controlled by a combined process of regulating 5-HT neuron firing through 5-HT autoreceptors, neurotransmitter release, enzymatic degradation, and reuptake by transporters. This study tests the hypothesis that activation of 5-HT1A autoreceptors, which would lessen 5-HT neuron firing, contributes to cocaine-seeking behaviors. Using 5-HT neuron-specific reduction of 5-HT1A autoreceptor gene expression in mice, we demonstrate that 5-HT1A autoreceptors are necessary for cocaine conditioned place preference. In addition, using designer receptors exclusively activated by designer drugs (DREADDs) technology, we found that stimulation of the serotonergic dorsal raphe nucleus (DRN) afferents to the nucleus accumbens (NAc) abolishes cocaine reward and promotes antidepressive-like behaviors. Finally, using a rat model of compulsive-like cocaine self-administration, we found that inhibition of dorsal raphe 5-HT1A autoreceptors attenuates cocaine self-administration in rats with 6 h extended access, but not 1 h access to the drug. Therefore, our findings suggest an important role for 5-HT1A autoreceptors, and thus DRNNAc 5-HT neuronal activity, in the etiology and vulnerability to cocaine reward and addiction. Moreover, our findings support a strategy for antagonizing 5-HT1A autoreceptors for treating cocaine addiction.

Indexed as

AnimalsAutoreceptorsCocaineCompulsive BehaviorConditioning, ClassicalDesigner DrugsDorsal Raphe NucleusDrug-Seeking BehaviorGene Knockdown TechniquesMaleMiceMotivationNeural PathwaysNucleus AccumbensRatsRats, WistarAutoreceptorsCocaineDesigner DrugsReceptor, Serotonin, 5-HT1ASerotonin 5-HT1 Receptor Antagonists

Identifiers

PMID26324408
PMCPMC4793105
OpenAlexW1265204934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.